KATHLEEN LICKFELDT: Open Payments
NPI 1821457870 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$153 in 8 payments from 7 companies in 2025. Trend: 2023 $381 · 2024 $300 · 2025 $153
Food & beverage: $153
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $34 |
| Cardiac Dimensions, Inc. | 1 | $27 |
| BridgeBio Pharma, Inc. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Attruby, OPSUMIT, WINREVAIR, ELIQUIS, JARDIANCE, FARXIGA.
Industry payments across PA — which companies pay providers there.
